Bacterial proteins and peptides in cancer therapy: today and tomorrow

Area of Science:

• Oncology
• Drug Discovery
• Microbiology

Background:

• Cancer remains a leading global cause of death.
• Traditional cancer therapies like tyrosine kinase inhibitors and monoclonal antibodies face limitations due to drug resistance and side effects.
• The
• one drug, one target
• paradigm is being challenged by emerging multi-targeted approaches.

Purpose of the Study:

• To discuss the challenges and potential of utilizing bacterial proteins and peptides.
• To propose a new generation of anti-cancer drugs based on multi-targeted therapy.
• To address the urgent need for novel therapeutic strategies against cancer.

Main Methods:

• Literature review on current cancer drug development paradigms.
• Analysis of existing targeted therapies and their limitations.
• Exploration of bacterial proteins and peptides as potential anti-cancer agents.

Main Results:

• Current targeted therapies exhibit significant limitations including drug resistance and adverse side effects.
• Multi-targeted approaches represent a promising new direction in cancer therapy.
• Bacterial proteins and peptides offer a novel source for developing next-generation anti-cancer drugs.

Conclusions:

• Overcoming therapeutic resistance in cancer requires innovative drug development strategies.
• Bacterial-derived compounds present a viable avenue for multi-targeted anti-cancer drug discovery.
• Further research into bacterial proteins and peptides is crucial for advancing cancer treatment.